
    
      To characterize meth. withdrawal symptoms using a multidimensional withdrawal questionnaire;
      to field test and investigate the effect of using an algorithm developed for discriminating
      between new use and residual carry-over of meth metabolites in urine and to evaluate the
      treatment response of meth. users to participation in the thrice weekly psychosocial protocol
      to be used as a "platform" in future pharmacotherapy trials.
    
  